U.S. Transportation Stock News

NYSE:RCL
NYSE:RCLHospitality

Royal Caribbean Rethinks Mexico Projects As Environmental Risks Shape Growth

Royal Caribbean Cruises (NYSE:RCL) is reassessing its investment plans in Mexico after local environmental authorities rejected a proposed water park project. The decision directly affects the company’s destination development pipeline in the region. Management is now reviewing how environmental constraints may influence future projects in sensitive coastal areas. For a company that relies on attractive ports of call and onshore experiences, this setback in Mexico is closely tied to how...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

AST SpaceMobile Draws Focus With US Carrier JV And 2x ETFs

AST SpaceMobile (NasdaqGS:ASTS) is positioned to participate in a new joint venture between AT&T, T-Mobile, and Verizon that aims to expand satellite-based direct-to-device wireless coverage across the US. Two new leveraged ETFs, the Defiance Daily Target 2X Long ASTS ETF and the T-REX 2X Long ASTS Daily Target ETF, have launched, offering 2x daily exposure to AST SpaceMobile's share price. The joint venture and ETF launches highlight rising industry and market attention on...
NYSE:ALLE
NYSE:ALLEBuilding

Assessing Allegion’s Valuation As New Campus To Community Platform Targets Student Housing Market

Campus-to-Community launch puts Allegion’s student housing push in focus Allegion (ALLE) has drawn fresh attention after unveiling its Campus-to-Community Student Living platform, a unified, mobile-first access system for off-campus student housing operators that connects hardware, mobile credentials and software partners. See our latest analysis for Allegion. The Campus-to-Community launch comes as Allegion’s stock trades at US$129.25, with the share price down 19.7% year to date and the 1...
NasdaqGS:EBAY
NasdaqGS:EBAYMultiline Retail

Ryan Cohen’s Activist Push Puts eBay’s Valuation And Governance In Focus

GameStop CEO Ryan Cohen has launched an activist campaign targeting NasdaqGS:EBAY after a high profile takeover bid was rejected. Cohen has increased GameStop's economic exposure to over 6% of eBay's shares through derivatives. He is publicly pressing eBay for leadership changes and operational restructuring, raising the prospect of a prolonged activist push. NasdaqGS:EBAY runs a global online marketplace that connects buyers and sellers across a wide range of product categories. The...
NYSE:AMCR
NYSE:AMCRPackaging

A Look At Amcor (AMCR) Valuation As Lift-Off Challenge And CNAS Accreditation Spotlight Growth Plans

Amcor (AMCR) is in the spotlight after launching its global Amcor Lift-Off Rigids challenge for packaging startups and securing CNAS accreditation for its Asia Pacific Innovation Center in China, sharpening attention on the stock. See our latest analysis for Amcor. Despite the Lift-Off Rigids challenge and the CNAS accreditation pointing to a more active growth agenda, Amcor’s 30 day share price return is down 8.55% and the 1 year total shareholder return is down 12.09%, suggesting sentiment...
NYSE:INFQ
NYSE:INFQTech

Infleqtion’s Quantum Funding And Defense Trials Set Against Share Pullback

Infleqtion (NYSE:INFQ) has secured a Letter of Intent with the U.S. Department of Commerce’s CHIPS R&D Office for substantial milestone-based funding to support its quantum hardware and systems work. The company has introduced Quantum Spectrum, an RF sensing technology that uses Rydberg atoms instead of traditional antennas. Quantum Spectrum is in active defense field trials across the US, UK, and Australia with major government and defense partners. For investors watching quantum computing...
NYSE:DE
NYSE:DEMachinery

Deere Lawsuit Puts Right To Repair And Service Profits In Focus

Deere (NYSE:DE) is facing a new right-to-repair class-action lawsuit filed by a Chicago landscaping business. The suit challenges Deere's repair policies for lawn, turf, and construction equipment, focusing on practices since May 2022. Plaintiffs allege Deere's repair model has led to higher repair costs and longer wait times for customers. The case follows earlier right-to-repair litigation involving farmers but targets a broader range of equipment users. Deere, known for its agricultural,...
NasdaqGS:EXEL
NasdaqGS:EXELBiotechs

How Investors May Respond To Exelixis (EXEL) Merck MRD+ Colorectal Cancer Trial Collaboration

Earlier in May 2026, Exelixis announced a clinical development collaboration with Merck, under which Exelixis will sponsor the planned phase 3 STELLAR-316 trial testing its investigational kinase inhibitor zanzalintinib with and without Merck’s subcutaneous KEYTRUDA QLEX in resected stage II/III colorectal cancer patients who are molecular residual disease–positive after definitive therapy. The partnership, which also incorporates Natera’s Signatera assay to identify eligible MRD+ patients,...
NYSEAM:IE
NYSEAM:IEMetals and Mining

A Look At Ivanhoe Electric (IE) Valuation After Quarterly Profit Turnaround And Recent Share Price Weakness

Ivanhoe Electric (IE) has drawn fresh attention after reporting first quarter 2026 results, shifting from a net loss a year ago to net income of US$41.74 million on sales of US$0.858 million. See our latest analysis for Ivanhoe Electric. Even with the strong quarterly result, Ivanhoe Electric’s share price return has been weak in the short term, with the stock down 25.81% year to date and 21.18% over the past month. The 1 year total shareholder return of 81.04% signals that longer term...
NYSE:TJX
NYSE:TJXSpecialty Retail

TJX Companies (TJX) Margin Improvement Reinforces Bullish Earnings Narrative Heading Into Q1 2027

TJX Companies (TJX) has set the tone for Q1 2027 earnings season with recent quarterly revenue of about US$17.7 billion, basic EPS of US$1.58 and net income of roughly US$1.8 billion anchoring the latest report. The company has seen revenue move from US$14.1 billion in Q3 2026 to US$17.7 billion in Q4 2026, while basic EPS over that stretch ranged from US$1.30 to US$1.58. This gives a clear view of how the top and bottom lines have been tracking into this quarter. Taken together with a higher...
NYSE:DLB
NYSE:DLBSoftware

A Look At Dolby Laboratories (DLB) Valuation After Recent Share Price Pullback

Context for Dolby Laboratories after recent share performance Dolby Laboratories (DLB) has drawn investor attention after the stock fell about 16% over the past month and roughly 16% over the past 3 months, against annual revenue of US$1.36b and net income of US$243.65m. See our latest analysis for Dolby Laboratories. At a share price of US$54.12, Dolby’s momentum has softened, with the stock down about 16% on a 1 month share price basis and its 1 year total shareholder return lower at around...
NYSE:GNK
NYSE:GNKShipping

A Look At Genco Shipping & Trading (GNK) Valuation After Recent Share Price Volatility

Event overview and recent performance snapshot Genco Shipping & Trading (GNK) is back on investors’ radar after a recent 1 day gain of 1.7%, in contrast to a decline of 5.4% over the past week and a modest slip over the past month. See our latest analysis for Genco Shipping & Trading. That short term setback over the past week sits alongside a 30.7% year to date share price return and an 87.9% total shareholder return over one year, suggesting momentum has cooled recently after a strong...
NasdaqGS:DNLI
NasdaqGS:DNLIBiotechs

Is Early AVLAYAH Demand Reshaping The Investment Case For Denali Therapeutics’ Rare-Disease Platform (DNLI)?

Denali Therapeutics recently reported a first-quarter 2026 net loss of US$128.45 million, slightly improving year on year, while also sharing updates on its initial commercial rollout of AVLAYAH for Hunter syndrome and presenting at industry and investor conferences earlier in May. The early, stronger-than-expected uptake of AVLAYAH is drawing attention to Denali’s brain-penetrant drug platform and its broader rare disease pipeline. We’ll now look at how robust early AVLAYAH demand may...
NasdaqGM:ADMA
NasdaqGM:ADMABiotechs

A Look At ADMA Biologics (ADMA) Valuation After Securities Fraud Probes And Guidance Withdrawal

Culper Research’s short report accusing ADMA Biologics (ADMA) of inflating revenue by encouraging a distributor to hold excess stock has triggered securities fraud investigations and multiple class action efforts, putting the company’s reported growth and guidance under scrutiny. See our latest analysis for ADMA Biologics. At a share price of US$8.56, ADMA’s recent legal headlines have coincided with sharp share price pressure, including a 30 day share price return down 21.32% and a 90 day...
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

Assessing TMC The Metals (TMC) Valuation After Transformational Allseas Commercial Nodule System Agreement

TMC the metals (TMC) has drawn fresh investor focus after signing a detailed development and commercial production agreement with Allseas to build and operate what the company expects will be the first commercial nodule collection system. See our latest analysis for TMC the metals. The Allseas agreement and recent Q1 update come against a mixed price backdrop, with the 1 day share price return of 1.8% contrasting with share price returns that are down around 10% over the past month and...
NYSE:HIMS
NYSE:HIMSHealthcare

Hims Launches Canadian Semaglutide Offering As GLP-1 And Valuation Story Evolves

Hims & Hers Health (NYSE:HIMS) has launched generic semaglutide for weight loss in Canada as part of its international expansion. This marks the company’s first introduction of a generic GLP-1 medication outside the U.S. The new offering targets obesity and metabolic health treatments for Canadian patients. Hims & Hers Health focuses on direct to consumer telehealth, using an AI driven platform to connect patients with personalized treatments across categories like mental health, sexual...
NasdaqGM:MNKD
NasdaqGM:MNKDBiotechs

How Revenue Jump And United Therapeutics Deal At MannKind (MNKD) Has Changed Its Investment Story

MannKind Corporation recently reported Q1 2026 revenues of US$90.2 million, a 15% year-on-year increase driven mainly by Furoscix net sales and Tyvaso DPI royalties, alongside an expanded collaboration with United Therapeutics that includes a US$5 million payment to accelerate Ralinepag DPI development. With key upcoming FDA action dates for Afrezza’s pediatric indication and the Furoscix ReadyFlow Autoinjector, MannKind’s revenue mix and partnership profile are becoming more closely tied to...
NYSE:WTS
NYSE:WTSMachinery

A Look At Watts Water Technologies (WTS) Valuation After Analyst Upgrades And Q1 Earnings Beat

Watts Water Technologies (WTS) is back in focus after recent analyst upgrades and a Q1 earnings beat highlighted solid organic sales growth, stronger data center demand, and better free cash flow margins. See our latest analysis for Watts Water Technologies. Despite the recent Q1 beat and M&A commentary, short term momentum has been mixed, with a 1 day share price return of 1.04% but a 90 day share price return down 9.16%, while the 1 year total shareholder return of 26.62% and 5 year total...
NasdaqGS:GLPI
NasdaqGS:GLPISpecialized REITs

How a Higher Q2 2026 Dividend Could Shape Gaming and Leisure Properties' (GLPI) Income Story

Gaming and Leisure Properties, Inc. previously announced that its Board approved a second-quarter 2026 cash dividend of US$0.82 per share, a 5% increase from the prior payout, payable on June 26, 2026 to shareholders of record on June 12, 2026. This higher dividend underscores the REIT’s emphasis on consistent cash distributions backed by recurring triple-net lease income from its gaming real estate portfolio. With this 5% dividend increase now in place, we’ll examine how a richer cash...
NYSE:AWK
NYSE:AWKWater Utilities

Is New Multistate Infrastructure Spending And Debt Issue Altering The Investment Case For American Water Works (AWK)?

In recent announcements, American Water Works’ subsidiaries outlined extensive 2026 infrastructure programs, including roughly US$277,000,000 in California, US$290,000,000 in Illinois, over US$40,000,000 in Tennessee, and about US$17,800,000 for Pennsylvania storage tanks, alongside completing a US$4,000,000 main replacement in Bellflower, California. Together with a new US$500,000,000 senior notes issue, these projects highlight the company’s heavy capital commitment to modernizing...
NasdaqGM:ARRY
NasdaqGM:ARRYElectrical

Array Technologies (ARRY) Is Down 6.0% After Surprise Q1 Profit And Record Order Book Update

Array Technologies recently reported a surprise Q1 2026 profit with adjusted EPS of US$0.06, beat revenue expectations, and ended the quarter with a record US$2.40 billion order book while forecasting strong revenue and EBITDA growth for the rest of the year. A new role as tracker supplier for Statkraft’s high‑altitude Lupi solar project in Peru underscores Array’s growing international footprint and ability to deploy its technology in demanding environments. With that backdrop of a surprise...
NYSE:AYI
NYSE:AYIElectrical

How Acuity’s New $800 Million Credit Facility At Acuity (AYI) Has Changed Its Investment Story

In May 2026, Acuity Inc. entered into a new unsecured revolving credit agreement led by JPMorgan Chase, replacing its 2022 facility and providing up to $800 million of availability maturing in May 2031, subject to leverage-based covenants and customary restrictions. This long-dated, flexible borrowing capacity, tied to Acuity’s leverage ratio or credit rating, gives the company additional financial room to support operations, acquisitions, and ongoing capital allocation choices. Next, we’ll...
NYSE:NU
NYSE:NUBanks

Does Record Q1 Profit and Rising Provisions Change The Bull Case For Nu Holdings (NU)?

In the past quarter, Nu Holdings Ltd. reported record first‑quarter 2026 results, with net income rising to US$872.06 million and basic earnings per share from continuing operations increasing to US$0.1796, alongside strong customer growth past 135 million and robust revenue expansion across Latin America. Despite this operational strength, the company’s slight earnings-per-share miss versus consensus and higher credit provisions in a tougher Latin American backdrop have raised fresh...
NYSE:PNR
NYSE:PNRMachinery

Will Pentair’s (PNR) Water Infrastructure Focus Amid Yearly Low Reshape Its Long-Term Narrative?

Pentair recently drew renewed attention after hitting a yearly trading low, even as it continues to report resilient operational performance in water treatment, filtration, and fluid management across residential, commercial, and industrial markets. This combination of operational resilience, cautious management commentary, and growing interest in long-cycle water infrastructure has sharpened investor focus on Pentair’s fundamentals and long-term role in global water systems. With investor...